{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T08:21:11Z","timestamp":1791534071365,"version":"4.3.4"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T00:00:00Z","timestamp":1529884800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00702-018-1898-9","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T13:27:23Z","timestamp":1529933243000},"page":"423-431","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["Is Braak staging valid for all types of Parkinson\u2019s disease?"],"prefix":"10.1007","volume":"126","author":[{"given":"Kurt A.","family":"Jellinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,25]]},"reference":[{"key":"1898_CR1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1159\/000122963","volume":"25","author":"L Aho","year":"2008","unstructured":"Aho L, Parkkinen L, Pirttila T, Alafuzoff I (2008) Systematic appraisal using immunohistochemistry of brain pathology in aged and demented subjects. Dement Geriatr Cogn Disord 25:423\u2013432","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1898_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00401-009-0523-2","volume":"117","author":"I Alafuzoff","year":"2009","unstructured":"Alafuzoff I, Ince PG, Arzberger T, Al-Sarraj S, Bell J, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kovacs GG, Meyronet D, Monoranu C, Parchi P, Parkkinen L, Patsouris E, Roggendorf W, Rozemuller A, Stadelmann-Nessler C, Streichenberger N, Thal DR, Kretzschmar H (2009) Staging\/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol 117:635\u2013652","journal-title":"Acta Neuropathol"},{"key":"1898_CR3","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1365-2990.2008.00937.x","volume":"34","author":"J Attems","year":"2008","unstructured":"Attems J, Jellinger KA (2008) The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson\u2019s disease. Neuropathol Appl Neurobiol 34:466\u2013467","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1898_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/nan.12303","volume":"42","author":"RA Barker","year":"2016","unstructured":"Barker RA, Williams-Gray CH (2016) Review: the spectrum of clinical features seen with alpha synuclein pathology. Neuropathol Appl Neurobiol 42:6\u201319","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1898_CR5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00401-007-0313-7","volume":"115","author":"TG Beach","year":"2008","unstructured":"Beach TG, Adler CH, Sue LI, Peirce JB, Bachalakuri J, Dalsing-Hernandez JE, Lue LF, Caviness JN, Connor DJ, Sabbagh MN, Walker DG (2008) Reduced striatal tyrosine hydroxylase in incidental Lewy body disease. Acta Neuropathol 115:445\u2013451","journal-title":"Acta Neuropathol"},{"key":"1898_CR6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","volume":"117","author":"TG Beach","year":"2009","unstructured":"Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J, Sasse J, Boyer S, Shirohi S, Brooks R, Eschbacher J, White CL III, Akiyama H, Caviness J, Shill HA, Connor DJ, Sabbagh MN, Walker DG, Arizona Parkinson\u2019s Disease Consortium (2009) Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117:613\u2013634","journal-title":"Acta Neuropathol"},{"key":"1898_CR7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","volume":"119","author":"TG Beach","year":"2010","unstructured":"Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, Akiyama H, Caviness JN, Shill HA, Sabbagh MN, Walker DG (2010) Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 119:689\u2013702","journal-title":"Acta Neuropathol"},{"key":"1898_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00702-017-1715-x","volume":"125","author":"J Blesa","year":"2018","unstructured":"Blesa J, Trigo-Damas I, Del Rey NL, Obeso JA (2018) The use of nonhuman primate models to understand processes in Parkinson\u2019s disease. J Neural Transm (Vienna) 125:325\u2013335","journal-title":"J Neural Transm (Vienna)"},{"key":"1898_CR9","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1365-2990.2006.00727.x","volume":"32","author":"A Bloch","year":"2006","unstructured":"Bloch A, Probst A, Bissig H, Adams H, Tolnay M (2006) Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurobiol 32:284\u2013295","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1898_CR10","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1212\/01.wnl.0000312279.49272.9f","volume":"70","author":"H Braak","year":"2008","unstructured":"Braak H, Del Tredici K (2008) Nervous system pathology in sporadic Parkinson disease. Neurology 70:1916\u20131925","journal-title":"Neurology"},{"key":"1898_CR11","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a023630","author":"H Braak","year":"2016","unstructured":"Braak H, Del Tredici K (2016) Potential pathways of abnormal tau and alpha-synuclein dissemination in sporadic Alzheimer\u2019s and Parkinson\u2019s diseases. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a023630","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1898_CR12","first-page":"S73","volume":"7","author":"H Braak","year":"2017","unstructured":"Braak H, Del Tredici K (2017) Neuropathological staging of brain pathology in sporadic Parkinson\u2019s disease: separating the wheat from the chaff. J Parkinsons Dis 7:S73\u2013S87","journal-title":"J Parkinsons Dis"},{"key":"1898_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"1898_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res 318:121\u2013134","journal-title":"Cell Tissue Res"},{"key":"1898_CR15","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1212\/01.WNL.0000158422.41380.82","volume":"64","author":"H Braak","year":"2005","unstructured":"Braak H, Rub U, Jansen Steur EN, Del Tredici K, de Vos RA (2005) Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 64:1404\u20131410","journal-title":"Neurology"},{"key":"1898_CR16","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1002\/mds.21065","volume":"21","author":"H Braak","year":"2006","unstructured":"Braak H, Bohl JR, Muller CM, Rub U, de Vos RA, Del Tredici K (2006) Stanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson\u2019s disease reconsidered. Mov Disord 21:2042\u20132051","journal-title":"Mov Disord"},{"key":"1898_CR17","doi-asserted-by":"publisher","first-page":"9808","DOI":"10.1523\/JNEUROSCI.1788-16.2017","volume":"37","author":"P Brundin","year":"2017","unstructured":"Brundin P, Melki R (2017) Prying into the prion hypothesis for Parkinson\u2019s disease. J Neurosci 37:9808\u20139818","journal-title":"J Neurosci"},{"key":"1898_CR18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/ana.21541","volume":"64","author":"RE Burke","year":"2008","unstructured":"Burke RE, Dauer WT, Vonsattel JP (2008) A critical evaluation of the Braak staging scheme for Parkinson\u2019s disease. Ann Neurol 64:485\u2013491","journal-title":"Ann Neurol"},{"key":"1898_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-018-2854-6","author":"S Chartier","year":"2018","unstructured":"Chartier S, Duyckaerts C (2018) Is Lewy pathology in the human nervous system chiefly an indicator of neuronal protection or of toxicity? Cell Tissue Res. https:\/\/doi.org\/10.1007\/s00441-018-2854-6","journal-title":"Cell Tissue Res"},{"key":"1898_CR20","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1126\/science.1138718","volume":"318","author":"J Collinge","year":"2007","unstructured":"Collinge J, Clarke AR (2007) A general model of prion strains and their pathogenicity. Science 318:930\u2013936","journal-title":"Science"},{"key":"1898_CR21","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1001\/archneur.65.8.1074","volume":"65","author":"A DelleDonne","year":"2008","unstructured":"DelleDonne A, Klos KJ, Fujishiro H, Ahmed Z, Parisi JE, Josephs KA, Frigerio R, Burnett M, Wszolek ZK, Uitti RJ, Ahlskog JE, Dickson DW (2008) Incidental Lewy body disease and preclinical Parkinson disease. Arch Neurol 65:1074\u20131080","journal-title":"Arch Neurol"},{"key":"1898_CR22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00401-008-0345-7","volume":"115","author":"DW Dickson","year":"2008","unstructured":"Dickson DW, Fujishiro H, DelleDonne A, Menke J, Ahmed Z, Klos KJ, Josephs KA, Frigerio R, Burnett M, Parisi JE, Ahlskog JE (2008) Evidence that incidental Lewy body disease is pre-symptomatic Parkinson\u2019s disease. Acta Neuropathol 115:437\u2013444","journal-title":"Acta Neuropathol"},{"key":"1898_CR23","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","volume":"8","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, Hardy J, Leverenz JB, Del Tredici K, Wszolek ZK, Litvan I (2009) Neuropathological assessment of Parkinson\u2019s disease: refining the diagnostic criteria. Lancet Neurol 8:1150\u20131157","journal-title":"Lancet Neurol"},{"issue":"Suppl 1","key":"1898_CR24","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1002\/mds.22637","volume":"25","author":"DW Dickson","year":"2010","unstructured":"Dickson DW, Uchikado H, Fujishiro H, Tsuboi Y (2010) Evidence in favor of Braak staging of Parkinson\u2019s disease. Mov Disord 25(Suppl 1):S78\u2013S82","journal-title":"Mov Disord"},{"key":"1898_CR25","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/mds.25952","volume":"29","author":"AA Dijkstra","year":"2014","unstructured":"Dijkstra AA, Voorn P, Berendse HW, Groenewegen HJ, Rozemuller AJ, van de Berg WD (2014) Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson\u2019s disease. Mov Disord 29:1244\u20131251","journal-title":"Mov Disord"},{"key":"1898_CR26","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s00401-005-0015-y","volume":"111","author":"ZT Ding","year":"2006","unstructured":"Ding ZT, Wang Y, Jiang YP, Hashizume Y, Yoshida M, Mimuro M, Inagaki T, Iwase T (2006) Characteristics of alpha-synucleinopathy in centenarians. Acta Neuropathol 111:450\u2013458","journal-title":"Acta Neuropathol"},{"key":"1898_CR27","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1212\/WNL.0000000000004146","volume":"89","author":"V Donadio","year":"2017","unstructured":"Donadio V, Incensi A, Rizzo G, Capellari S, Pantieri R, Stanzani Maserati M, Devigili G, Eleopra R, Defazio G, Montini F, Baruzzi A, Liguori R (2017) A new potential biomarker for dementia with Lewy bodies: skin nerve alpha-synuclein deposits. Neurology 89:318\u2013326","journal-title":"Neurology"},{"key":"1898_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-018-1171-z","volume":"15","author":"MF Duffy","year":"2018","unstructured":"Duffy MF, Collier TJ, Patterson JR, Kemp CJ, Luk KC, Tansey MG, Paumier KL, Kanaan NM, Fischer DL, Polinski NK, Barth OL, Howe JW, Vaikath NN, Majbour NK, El-Agnaf OMA, Sortwell CE (2018) Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration. J Neuroinflammation 15:129","journal-title":"J Neuroinflammation"},{"key":"1898_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00401-017-1787-6","volume":"135","author":"D Erskine","year":"2018","unstructured":"Erskine D, Patterson L, Alexandris A, Hanson PS, McKeith IG, Attems J, Morris CM (2018) Regional levels of physiological alpha-synuclein are directly associated with Lewy body pathology. Acta Neuropathol 135:153\u2013154","journal-title":"Acta Neuropathol"},{"issue":"Pt 5","key":"1898_CR30","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley JM, Lees AJ (1991) Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity. Brain 114(Pt 5):2283\u20132301","journal-title":"Brain"},{"key":"1898_CR31","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1212\/WNL.0b013e31822c9148","volume":"77","author":"TJ Ferman","year":"2011","unstructured":"Ferman TJ, Boeve BF, Smith GE, Lin SC, Silber MH, Pedraza O, Wszolek Z, Graff-Radford NR, Uitti R, Van Gerpen J, Pao W, Knopman D, Pankratz VS, Kantarci K, Boot B, Parisi JE, Dugger BN, Fujishiro H, Petersen RC, Dickson DW (2011) Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. Neurology 77:875\u2013882","journal-title":"Neurology"},{"key":"1898_CR32","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00702-010-0482-8","volume":"118","author":"I Ferrer","year":"2011","unstructured":"Ferrer I, Martinez A, Blanco R, Dalfo E, Carmona M (2011) Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease. J Neural Transm (Vienna) 118:821\u2013839","journal-title":"J Neural Transm (Vienna)"},{"key":"1898_CR33","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neurobiolaging.2009.05.019","volume":"32","author":"R Frigerio","year":"2011","unstructured":"Frigerio R, Fujishiro H, Ahn TB, Josephs KA, Maraganore DM, Delledonne A, Parisi JE, Klos KJ, Boeve BF, Dickson DW, Ahlskog JE (2011) Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies? Neurobiol Aging 32:857\u2013863","journal-title":"Neurobiol Aging"},{"key":"1898_CR34","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/nen.0b013e3180517454","volume":"66","author":"Y Fumimura","year":"2007","unstructured":"Fumimura Y, Ikemura M, Saito Y, Sengoku R, Kanemaru K, Sawabe M, Arai T, Ito G, Iwatsubo T, Fukayama M, Mizusawa H, Murayama S (2007) Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in Lewy body disease. J Neuropathol Exp Neurol 66:354\u2013362","journal-title":"J Neuropathol Exp Neurol"},{"key":"1898_CR35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF00695605","volume":"64","author":"P Gaspar","year":"1984","unstructured":"Gaspar P, Gray F (1984) Dementia in idiopathic Parkinson\u2019s disease. A neuropathological study of 32 cases. Acta Neuropathol 64:43\u201352","journal-title":"Acta Neuropathol"},{"key":"1898_CR36","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev-neuro-072116-031153","volume":"40","author":"M Goedert","year":"2017","unstructured":"Goedert M, Eisenberg DS, Crowther RA (2017a) Propagation of tau aggregates and neurodegeneration. Annu Rev Neurosci 40:189\u2013210","journal-title":"Annu Rev Neurosci"},{"key":"1898_CR37","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/brain\/aww230","volume":"140","author":"M Goedert","year":"2017","unstructured":"Goedert M, Masuda-Suzukake M, Falcon B (2017b) Like prions: the propagation of aggregated tau and alpha-synuclein in neurodegeneration. Brain 140:266\u2013278","journal-title":"Brain"},{"key":"1898_CR38","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1001\/archneur.63.4.584","volume":"63","author":"S Greffard","year":"2006","unstructured":"Greffard S, Verny M, Bonnet AM, Beinis JY, Gallinari C, Meaume S, Piette F, Hauw JJ, Duyckaerts C (2006) Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra. Arch Neurol 63:584\u2013588","journal-title":"Arch Neurol"},{"key":"1898_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neurobiolaging.2008.03.015","volume":"31","author":"S Greffard","year":"2010","unstructured":"Greffard S, Verny M, Bonnet AM, Seilhean D, Hauw JJ, Duyckaerts C (2010) A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death. Neurobiol Aging 31:99\u2013103","journal-title":"Neurobiol Aging"},{"key":"1898_CR40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","volume":"154","author":"JL Guo","year":"2013","unstructured":"Guo JL, Covell DJ, Daniels JP, Iba M, Stieber A, Zhang B, Riddle DM, Kwong LK, Xu Y, Trojanowski JQ, Lee VM (2013) Distinct alpha-synuclein strains differentially promote tau inclusions in neurons. Cell 154:103\u2013117","journal-title":"Cell"},{"key":"1898_CR41","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1749-6632.2009.05118.x","volume":"1184","author":"GM Halliday","year":"2010","unstructured":"Halliday GM, McCann H (2010) The progression of pathology in Parkinson\u2019s disease. Ann N Y Acad Sci 1184:188\u2013195","journal-title":"Ann N Y Acad Sci"},{"key":"1898_CR42","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/B978-1-4160-6641-5.00009-X","volume-title":"Movement disorders 4","author":"G Halliday","year":"2010","unstructured":"Halliday G, Murphy K (2010) Pathology of Parkinson\u2019s disease\u2014an overview. In: Schapira AHV, Lang AET, Fahn S (eds) Movement disorders 4. Saunders-Elsevier, Philadelphia, pp\u00a0132\u2013154"},{"key":"1898_CR43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/mds.23455","volume":"26","author":"GM Halliday","year":"2011","unstructured":"Halliday GM, Stevens CH (2011) Glia: initiators and progressors of pathology in Parkinson\u2019s disease. Mov Disord 26:6\u201317","journal-title":"Mov Disord"},{"key":"1898_CR44","first-page":"99","volume":"Suppl","author":"GM Halliday","year":"2006","unstructured":"Halliday GM, Del Tredici K, Braak H (2006) Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson\u2019s disease. J Neural Transm Suppl:99\u2013103","journal-title":"J Neural Transm"},{"key":"1898_CR45","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-008-0344-8","volume":"115","author":"G Halliday","year":"2008","unstructured":"Halliday G, Hely M, Reid W, Morris J (2008) The progression of pathology in longitudinally followed patients with Parkinson\u2019s disease. Acta Neuropathol 115:409\u2013415","journal-title":"Acta Neuropathol"},{"key":"1898_CR46","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00702-011-0641-6","volume":"118","author":"GM Halliday","year":"2011","unstructured":"Halliday GM, Song YJ, Harding AJ (2011) Striatal beta-amyloid in dementia with Lewy bodies but not Parkinson\u2019s disease. J Neural Transm 118:713\u2013719","journal-title":"J Neural Transm"},{"key":"1898_CR47","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1212\/WNL.0000000000002102","volume":"85","author":"D Iacono","year":"2015","unstructured":"Iacono D, Geraci-Erck M, Rabin ML, Adler CH, Serrano G, Beach TG, Kurlan R (2015) Parkinson disease and incidental Lewy body disease: just a question of time? Neurology 85:1670\u20131679","journal-title":"Neurology"},{"key":"1898_CR48","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00401-003-0725-y","volume":"106","author":"KA Jellinger","year":"2003","unstructured":"Jellinger KA (2003) Alpha-synuclein pathology in Parkinson and Alzheimer disease brain: incidence and topographic distribution\u2014a pilot study. Acta Neuropathol 106:191\u2013201","journal-title":"Acta Neuropathol"},{"key":"1898_CR49","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00702-004-0138-7","volume":"111","author":"KA Jellinger","year":"2004","unstructured":"Jellinger KA (2004) Lewy body-related alpha-synucleinopathy in the aged human brain. J Neural Transm (Vienna) 111:1219\u20131235","journal-title":"J Neural Transm (Vienna)"},{"key":"1898_CR50","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.bbadis.2008.07.006","volume":"1792","author":"KA Jellinger","year":"2009","unstructured":"Jellinger KA (2009a) A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. Biochim Biophys Acta 1792:730\u2013740","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl 3","key":"1898_CR51","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s00415-009-5243-y","volume":"256","author":"KA Jellinger","year":"2009","unstructured":"Jellinger KA (2009b) Formation and development of Lewy pathology: a critical update. J Neurol 256(Suppl 3):270\u2013279","journal-title":"J Neurol"},{"key":"1898_CR52","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/mds.23795","volume":"27","author":"KA Jellinger","year":"2012","unstructured":"Jellinger KA (2012) Neuropathology of sporadic Parkinson\u2019s disease: evaluation and changes of concepts. Mov Disord 27:8\u201330","journal-title":"Mov Disord"},{"key":"1898_CR53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-3-319-08046-8_2","volume-title":"Inflammation in Parkinson\u2019s disease: scientific and clinical aspects","author":"KA Jellinger","year":"2014","unstructured":"Jellinger KA (2014) Neuropathology of Parkinson\u2019s disease. In: Thomas M (ed) Inflammation in Parkinson\u2019s disease: scientific and clinical aspects. Springer, New York, pp\u00a025\u201347"},{"key":"1898_CR54","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1365-2990.2007.00923.x","volume":"34","author":"ME Kalaitzakis","year":"2008","unstructured":"Kalaitzakis ME, Graeber MB, Gentleman SM, Pearce RK (2008) The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson\u2019s disease: a critical analysis of alpha-synuclein staging. Neuropathol Appl Neurobiol 34:284\u2013295","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1898_CR55","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1093\/brain\/awq059","volume":"133","author":"PA Kempster","year":"2010","unstructured":"Kempster PA, O\u2019Sullivan SS, Holton JL, Revesz T, Lees AJ (2010) Relationships between age and late progression of Parkinson\u2019s disease: a clinico-pathological study. Brain 133:1755\u20131762","journal-title":"Brain"},{"key":"1898_CR56","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1002\/mds.23305","volume":"25","author":"AE Kingsbury","year":"2010","unstructured":"Kingsbury AE, Bandopadhyay R, Silveira-Moriyama L, Ayling H, Kallis C, Sterlacci W, Maeir H, Poewe W, Lees AJ (2010) Brain stem pathology in Parkinson\u2019s disease: an evaluation of the Braak staging model. Mov Disord 25:2508\u20132515","journal-title":"Mov Disord"},{"key":"1898_CR57","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nrneurol.2015.197","volume":"11","author":"L Klingelhoefer","year":"2015","unstructured":"Klingelhoefer L, Reichmann H (2015) Pathogenesis of Parkinson disease\u2014the gut\u2013brain axis and environmental factors. Nat Rev Neurol 11:625\u2013636","journal-title":"Nat Rev Neurol"},{"key":"1898_CR58","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1093\/brain\/awt192","volume":"136","author":"JH Kordower","year":"2013","unstructured":"Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, Halliday GM, Bartus RT (2013) Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease. Brain 136:2419\u20132431","journal-title":"Brain"},{"key":"1898_CR59","first-page":"299","volume":"7","author":"K Kosaka","year":"1988","unstructured":"Kosaka K, Tsuchiya K, Yoshimura M (1988) Lewy body disease with and without dementia: a clinicopathological study of 35 cases. Clin Neuropathol 7:299\u2013305","journal-title":"Clin Neuropathol"},{"key":"1898_CR60","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1002\/mds.22207","volume":"23","author":"GG Kovacs","year":"2008","unstructured":"Kovacs GG, Milenkovic IJ, Preusser M, Budka H (2008) Nigral burden of alpha-synuclein correlates with striatal dopamine deficit. Mov Disord 23:1608\u20131612","journal-title":"Mov Disord"},{"key":"1898_CR61","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00401-012-0964-x","volume":"124","author":"GG Kovacs","year":"2012","unstructured":"Kovacs GG, Wagner U, Dumont B, Pikkarainen M, Osman AA, Streichenberger N, Leisser I, Verchere J, Baron T, Alafuzoff I, Budka H, Perret-Liaudet A, Lachmann I (2012) An antibody with high reactivity for disease-associated alpha-synuclein reveals extensive brain pathology. Acta Neuropathol 124:37\u201350","journal-title":"Acta Neuropathol"},{"key":"1898_CR62","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3233\/JPD-2011-11061","volume":"1","author":"T Lebouvier","year":"2011","unstructured":"Lebouvier T, Pouclet H, Coron E, Drouard A, N\u2019Guyen JM, Roy M, Vavasseur F, Bruley des Varannes S, Damier P, Neunlist M, Derkinderen P, Rouaud T (2011) Colonic neuropathology is independent of olfactory dysfunction in Parkinson\u2019s disease. J Parkinsons Dis 1:389\u2013394","journal-title":"J Parkinsons Dis"},{"key":"1898_CR63","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1750-3639.2007.00117.x","volume":"18","author":"JB Leverenz","year":"2008","unstructured":"Leverenz JB, Hamilton R, Tsuang DW, Schantz A, Vavrek D, Larson EB, Kukull WA, Lopez O, Galasko D, Masliah E, Kaye J, Woltjer R, Clark C, Trojanowski JQ, Montine TJ (2008) Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathol 18:220\u2013224","journal-title":"Brain Pathol"},{"key":"1898_CR64","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1136\/jnnp.2003.033530","volume":"76","author":"SJ Lewis","year":"2005","unstructured":"Lewis SJ, Foltynie T, Blackwell AD, Robbins TW, Owen AM, Barker RA (2005) Heterogeneity of Parkinson\u2019s disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 76:343\u2013348","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1898_CR65","doi-asserted-by":"publisher","first-page":"5012129","DOI":"10.1155\/2017\/5012129","volume":"2017","author":"F Longhena","year":"2017","unstructured":"Longhena F, Faustini G, Missale C, Pizzi M, Spano P, Bellucci A (2017) The contribution of alpha-synuclein spreading to Parkinson\u2019s disease synaptopathy. Neural Plast 2017:5012129","journal-title":"Neural Plast"},{"key":"1898_CR66","doi-asserted-by":"publisher","first-page":"E1611","DOI":"10.3390\/ijms19061611","volume":"19","author":"F Longhena","year":"2018","unstructured":"Longhena F, Faustini G, Missale C, Pizzi M, Bellucci A (2018) Dopamine transporter\/alpha-synuclein complexes are altered in the post mortem caudate putamen of Parkinson\u2019s disease: an in situ proximity ligation assay study. Int J Mol Sci 19:E1611","journal-title":"Int J Mol Sci"},{"key":"1898_CR67","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","volume":"47","author":"IG McKeith","year":"1996","unstructured":"McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113\u20131124","journal-title":"Neurology"},{"key":"1898_CR68","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O\u2019Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89:88\u2013100","journal-title":"Neurology"},{"key":"1898_CR69","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/jnen\/64.2.156","volume":"64","author":"I Mikolaenko","year":"2005","unstructured":"Mikolaenko I, Pletnikova O, Kawas CH, O\u2019Brien R, Resnick SM, Crain B, Troncoso JC (2005) Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA). J Neuropathol Exp Neurol 64:156\u2013162","journal-title":"J Neuropathol Exp Neurol"},{"key":"1898_CR70","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1212\/WNL.0b013e318278fe32","volume":"79","author":"JM Milber","year":"2012","unstructured":"Milber JM, Noorigian JV, Morley JF, Petrovitch H, White L, Ross GW, Duda JE (2012) Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease. Neurology 79:2307\u20132314","journal-title":"Neurology"},{"key":"1898_CR71","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1097\/01.jnen.0000230520.47768.1a","volume":"65","author":"F Mori","year":"2006","unstructured":"Mori F, Nishie M, Kakita A, Yoshimoto M, Takahashi H, Wakabayashi K (2006) Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra. J Neuropathol Exp Neurol 65:808\u2013815","journal-title":"J Neuropathol Exp Neurol"},{"key":"1898_CR72","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/01.jnen.0000171652.40083.15","volume":"64","author":"CM M\u00fcller","year":"2005","unstructured":"M\u00fcller CM, de Vos RA, Maurage CA, Thal DR, Tolnay M, Braak H (2005) Staging of sporadic Parkinson disease-related alpha-synuclein pathology: inter- and intra-rater reliability. J Neuropathol Exp Neurol 64:623\u2013628","journal-title":"J Neuropathol Exp Neurol"},{"key":"1898_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2018.06.025","author":"GW O'Keeffe","year":"2018","unstructured":"O'Keeffe GW, Sullivan AM (2018) Evidence for dopaminergic axonal degeneration as an early pathological process in Parkinson's disease. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.06.025","journal-title":"Parkinsonism Relat Disord"},{"key":"1898_CR74","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1750-3639.2006.00032.x","volume":"17","author":"S Orimo","year":"2007","unstructured":"Orimo S, Takahashi A, Uchihara T, Mori F, Kakita A, Wakabayashi K, Takahashi H (2007) Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson\u2019s disease. Brain Pathol 17:24\u201330","journal-title":"Brain Pathol"},{"key":"1898_CR75","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/jnen\/62.4.363","volume":"62","author":"L Parkkinen","year":"2003","unstructured":"Parkkinen L, Soininen H, Alafuzoff I (2003) Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease. J Neuropathol Exp Neurol 62:363\u2013367","journal-title":"J Neuropathol Exp Neurol"},{"key":"1898_CR76","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00401-008-0346-6","volume":"115","author":"L Parkkinen","year":"2008","unstructured":"Parkkinen L, Pirttila T, Alafuzoff I (2008) Applicability of current staging\/categorization of alpha-synuclein pathology and their clinical relevance. Acta Neuropathol 115:399\u2013407","journal-title":"Acta Neuropathol"},{"key":"1898_CR77","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3233\/JPD-2011-11046","volume":"1","author":"L Parkkinen","year":"2011","unstructured":"Parkkinen L, O\u2019Sullivan SS, Collins C, Petrie A, Holton JL, Revesz T, Lees AJ (2011) Disentangling the relationship between lewy bodies and nigral neuronal loss in Parkinson\u2019s disease. J Parkinsons Dis 1:277\u2013286","journal-title":"J Parkinsons Dis"},{"key":"1898_CR78","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature14547","volume":"522","author":"W Peelaerts","year":"2015","unstructured":"Peelaerts W, Bousset L, Van der Perren A, Moskalyuk A, Pulizzi R, Giugliano M, Van den Haute C, Melki R, Baekelandt V (2015) Alpha-synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522:340\u2013344","journal-title":"Nature"},{"key":"1898_CR79","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-00018-02839-00445","author":"W Peelaerts","year":"2018","unstructured":"Peelaerts W, Bousset L, Baekelandt V, Melki R (2018) a-Synuclein strains and seeding in Parkinson\u2019s disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences. Cell Tissue Res. https:\/\/doi.org\/10.1007\/s00441-00018-02839-00445 (online)","journal-title":"Cell Tissue Res"},{"key":"1898_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-41018-40104-41584","author":"C Peng","year":"2018","unstructured":"Peng C, Gathagan RJ, Covell DJ, Medellin C, Stieber A, Robinson JL, Zhang B, Pitkin RM, Olufemi MF, Luk KC, Trojanowski JQ, Lee VM (2018) Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies. Nature. https:\/\/doi.org\/10.1038\/s41586-41018-40104-41584 (online)","journal-title":"Nature"},{"key":"1898_CR81","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.parkreldis.2017.01.009","volume":"37","author":"AH Rajput","year":"2017","unstructured":"Rajput AH, Rajput EF (2017) Octogenarian parkinsonism\u2014clinicopathological observations. Parkinsonism Relat Disord 37:50\u201357","journal-title":"Parkinsonism Relat Disord"},{"key":"1898_CR82","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/nan.12299","volume":"42","author":"NL Rey","year":"2016","unstructured":"Rey NL, George S, Brundin P (2016) Review: spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein. Neuropathol Appl Neurobiol 42:51\u201376","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1898_CR83","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fneur.2017.00037","volume":"8","author":"CD Rietdijk","year":"2017","unstructured":"Rietdijk CD, Perez-Pardo P, Garssen J, van Wezel RJ, Kraneveld AD (2017) Exploring Braak\u2019s hypothesis of Parkinson\u2019s disease. Front Neurol 8:37","journal-title":"Front Neurol"},{"key":"1898_CR84","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/mds.27193","volume":"32","author":"SA Schneider","year":"2017","unstructured":"Schneider SA, Alcalay RN (2017) Neuropathology of genetic synucleinopathies with parkinsonism: review of the literature. Mov Disord 32:1504\u20131523","journal-title":"Mov Disord"},{"key":"1898_CR85","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1093\/brain\/awp234","volume":"132","author":"M Selikhova","year":"2009","unstructured":"Selikhova M, Williams DR, Kempster PA, Holton JL, Revesz T, Lees AJ (2009) A clinico-pathological study of subtypes in Parkinson\u2019s disease. Brain 132:2947\u20132957","journal-title":"Brain"},{"key":"1898_CR86","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-018-2814-1","author":"JA Steiner","year":"2018","unstructured":"Steiner JA, Quansah E, Brundin P (2018) The concept of alpha-synuclein as a prion-like protein: ten years after. Cell Tissue Res. https:\/\/doi.org\/10.1007\/s00441-018-2814-1","journal-title":"Cell Tissue Res"},{"key":"1898_CR87","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier DJ, Obeso JA, Halliday GM (2017) Selective neuronal vulnerability in Parkinson disease. Nat Rev Neurosci 18:101\u2013113","journal-title":"Nat Rev Neurosci"},{"key":"1898_CR88","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00401-015-1526-9","volume":"131","author":"JB Toledo","year":"2016","unstructured":"Toledo JB, Gopal P, Raible K, Irwin DJ, Brettschneider J, Sedor S, Waits K, Boluda S, Grossman M, Van Deerlin VM, Lee EB, Arnold SE, Duda JE, Hurtig H, Lee VM, Adler CH, Beach TG, Trojanowski JQ (2016) Pathological alpha-synuclein distribution in subjects with coincident Alzheimer\u2019s and Lewy body pathology. Acta Neuropathol 131:393\u2013409","journal-title":"Acta Neuropathol"},{"key":"1898_CR89","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/B978-1-4160-6641-5.00014-3","volume-title":"Movement disorders 4","author":"E Tolosa","year":"2010","unstructured":"Tolosa E, Santamaria J, Gaig C, Compta Y (2010) Nonmotor aspects of Parkinson\u2019s disease. In: Schapira AHV, Lang AET, Fahn S (eds) Movement disorders 4. Saunders-Elsevier, Philadelphia, pp\u00a0229\u2013251"},{"key":"1898_CR90","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/neup.12348","volume":"37","author":"T Uchihara","year":"2017","unstructured":"Uchihara T (2017) An order in Lewy body disorders: retrograde degeneration in hyperbranching axons as a fundamental structural template accounting for focal\/multifocal Lewy body disease. Neuropathology 37:129\u2013149","journal-title":"Neuropathology"},{"key":"1898_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2018.06.030","author":"TC Vale","year":"2018","unstructured":"Vale TC, Barbosa MT, Resende EPF, Maia DP, Cunningham MCQ, Guimaraes HC, Machado JCB, Teixeira AL, Cardoso F, Caramelli P (2018) Parkinsonism in a population-based study of individuals aged 75+ years: The Pieta study. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.06.030","journal-title":"Parkinsonism Relat Disord"},{"issue":"Suppl 1","key":"1898_CR92","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/S1353-8020(11)70011-6","volume":"18","author":"WD Berg van de","year":"2012","unstructured":"van de Berg WD, Hepp DH, Dijkstra AA, Rozemuller JA, Berendse HW, Foncke E (2012) Patterns of alpha-synuclein pathology in incidental cases and clinical subtypes of Parkinson\u2019s disease. Parkinsonism Relat Disord 18(Suppl 1):S28\u2013S30","journal-title":"Parkinsonism Relat Disord"},{"key":"1898_CR93","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/2051-5960-1-2","volume":"1","author":"NP Visanji","year":"2013","unstructured":"Visanji NP, Brooks PL, Hazrati LN, Lang AE (2013) The prion hypothesis in Parkinson\u2019s disease: Braak to the future. Acta Neuropathol Commun 1:2","journal-title":"Acta Neuropathol Commun"},{"key":"1898_CR94","first-page":"1033","volume":"45","author":"K Wakabayashi","year":"1993","unstructured":"Wakabayashi K, Takahashi H, Oyanagi K, Ikuta F (1993) Incidental occurrence of Lewy bodies in the brains of elderly patients\u2014the relevance to aging and Parkinson\u2019s disease. No To Shinkei 45:1033\u20131038","journal-title":"No To Shinkei"},{"key":"1898_CR95","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s00401-003-0750-x","volume":"106","author":"Y Wakisaka","year":"2003","unstructured":"Wakisaka Y, Furuta A, Tanizaki Y, Kiyohara Y, Iida M, Iwaki T (2003) Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study. Acta Neuropathol 106:374\u2013382","journal-title":"Acta Neuropathol"},{"key":"1898_CR96","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-neuro-071714-033828","volume":"38","author":"LC Walker","year":"2015","unstructured":"Walker LC, Jucker M (2015) Neurodegenerative diseases: expanding the prion concept. Annu Rev Neurosci 38:87\u2013103","journal-title":"Annu Rev Neurosci"},{"key":"1898_CR97","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1212\/01.wnl.0000266626.64913.0f","volume":"69","author":"D Weisman","year":"2007","unstructured":"Weisman D, Cho M, Taylor C, Adame A, Thal LJ, Hansen LA (2007) In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution. Neurology 69:356\u2013359","journal-title":"Neurology"},{"key":"1898_CR98","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1212\/01.wnl.0000306697.48738.b6","volume":"70","author":"J Zaccai","year":"2008","unstructured":"Zaccai J, Brayne C, McKeith I, Matthews F, Ince PG (2008) Patterns and stages of alpha-synucleinopathy: relevance in a population-based cohort. Neurology 70:1042\u20131048","journal-title":"Neurology"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-018-1898-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-018-1898-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-018-1898-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T09:57:32Z","timestamp":1693735052000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-018-1898-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,25]]},"references-count":98,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["1898"],"URL":"https:\/\/doi.org\/10.1007\/s00702-018-1898-9","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,25]]},"assertion":[{"value":"6 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}